{
    "clinical_study": {
        "@rank": "164960", 
        "acronym": "DTS Register", 
        "brief_summary": {
            "textblock": "The DTS.DE registry is an initiative for the collection of high quality process and\n      historical data of implantations with the COMBO Dual Therapy Stent in Germany. DTS.DE was\n      designed as a national, non- randomized, prospective, multicenter registry without a\n      comparison group.\n\n      The responsible Steering Committee is of the opinion that the Combo stent qualifies for\n      further documentation of treatment results in the form of a German registry, based the CE\n      certification of the COMBO Dual Therapy stent in 2013 and its clinical and scientific\n      investigation in the context of the REMEDEE study program, as well as company independent\n      externally initiated studies with the COMBO Dual Therapy Stent.\n\n      It is expected that by mid- 2015, at least 1,000 patients will be enrolled and documented in\n      the DTS.DE registry with the COMBO Dual Therapy Stent. A clinical follow-up is performed\n      after 6 weeks and 12 months."
        }, 
        "brief_title": "Deutsches Dual Therapy Stent Register", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "It is the objective of the DTS.DE registry to capture the documentation of all patients  who\n      have been treated with a Combo Dual Therapy Stent in Germany, and who have been properly\n      informed and consented with regards to their participation in the registry. All of these\n      patients will be registered in the electronic data capturing system (eCRF) of the DTS.DE\n      registry and will be followed and documented for a period of 12 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients has at least one coronary lesion, suitable for PCI treatment with the Combo\n             stent in accordance with European Society of Cardiology Guidelines and local\n             Guidelines of the Deutsche Gesellschaft f\u00fcr Kardiologie for drug eluting stents\n\n        Exclusion Criteria:\n\n          -  Patient has previously received murine therapeutic antibodies and exhibited\n             sensitization through the production of Human Anti- Murine Antibodies (HAMA)\n\n          -  Patient in whom anti-platelet and/or anticoagulant therapy is contraindicated\n\n          -  Patient in whom a complete inflation of the angioplasty balloon or correct stent\n             placement is thought to be inhibited"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All patients in Germany who have undergone PCI with the COMBO Dual Therapy Stent."
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02102997", 
            "org_study_id": "DTS.DE Register V 1.2"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "DTS", 
            "Stents", 
            "Stent", 
            "DES", 
            "Drug eluting", 
            "Drug Eluting Stent (DES)", 
            "Drug eluting stents", 
            "Endothelial Progenitor Cell (EPC)", 
            "Endothelial progenitor cell capturing", 
            "Sirolimus", 
            "Sirolimus eluting", 
            "Percutaneous Coronary Intervention (PCI)", 
            "PCI", 
            "Registry", 
            "Registries", 
            "Multi center", 
            "Multi centre"
        ], 
        "lastchanged_date": "March 31, 2014", 
        "location": {
            "contact": {
                "email": "mhaude@lukasneuss.de", 
                "last_name": "Michael Haude, MD, PhD", 
                "phone": "+4921318882000"
            }, 
            "facility": {
                "address": {
                    "city": "Neuss", 
                    "country": "Germany", 
                    "zip": "D-41464"
                }, 
                "name": "Kardiologie Lukaskrankenhaus Neuss"
            }, 
            "investigator": {
                "last_name": "Michael Haude, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "Deutsches Dual Therapy Stent Register", 
        "overall_contact": {
            "email": "erdmann.zippel@aptivsolutions.com", 
            "last_name": "Erdmann Zippel", 
            "phone": "+49 6202 127360"
        }, 
        "overall_official": [
            {
                "affiliation": "Universit\u00e4tsklinikum Ulm, Klinik f\u00fcr Innere Medizin II Albert-Einstein-Allee 23, 89081 Ulm, Germany", 
                "last_name": "Jochen W\u00f6hrle, MD, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Kardiologie Lukaskrankenhaus Neuss Preu\u00dfenstra\u00dfe 84 D-41464 Neuss, Germany", 
                "last_name": "Michael Haude, MD, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Klinik f\u00fcr Kardiologie, Zentralklinik Bad Berka GmbH, Robert-Koch-Allee 9 99437 Bad Berka, Germany", 
                "last_name": "Bernward Lauer, MD, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Kardiologie, Angiologie, Pneumologie, Intensivmedizin Klinikum Fulda gAG Pacelliallee 4 - 36043 Fulda, Germany", 
                "last_name": "Volker Sch\u00e4chinger, MD, PhD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "TVF is defined as the hierarchical composite of target vessel related Major Adverse Cardiac Events (MACE). MACE is defined as the composite of death, myocardial infarction and  target lesion revascularization (TLR).", 
            "measure": "Target Vessel Failure (TVF)", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02102997"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Successful implantation of the stent and a residual stenosis of less than 20%", 
                "measure": "Procedural success", 
                "safety_issue": "Yes", 
                "time_frame": "Day of procedure"
            }, 
            {
                "description": "MACE is defined as the composite of of death, myocardial infarction and target lesion revascularization", 
                "measure": "MACE", 
                "safety_issue": "Yes", 
                "time_frame": "6 weeks and 12 months"
            }, 
            {
                "measure": "Stent induced serious adverse events (SAE)", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Classified per ARC definitions as definite, probable or possible stent thrombosis", 
                "measure": "Stent thrombosis", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Bleeding as defined by the TIMI criteria: major, minor or minimal", 
                "measure": "Thrombolysis in Myocardial Infarction (TIMI) bleeding", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }
        ], 
        "source": "OrbusNeich", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "OrbusNeich", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Observational Model: Ecologic or Community, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "12 Months", 
        "verification_date": "March 2014"
    }
}